| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |